Log in to save to my catalogue

SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregula...

SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregula...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_469ec52418bc4d8eb0ef6499688e03e5

SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation

About this item

Full title

SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2023-01, Vol.14 (1), p.132-132, Article 132

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

As an inherited disorder characterized by severe pulmonary disease, cystic fibrosis could be considered a comorbidity for coronavirus disease 2019. Instead, current clinical evidence seems to be heading in the opposite direction. To clarify whether host factors expressed by the Cystic Fibrosis epithelia may influence coronavirus disease 2019 progre...

Alternative Titles

Full title

SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_469ec52418bc4d8eb0ef6499688e03e5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_469ec52418bc4d8eb0ef6499688e03e5

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-023-35862-0

How to access this item